J Am Acad Orthop Surg Glob Res Rev 2020 11;4(11):e20.00028
From the Department of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY (Healey); Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Santa Monica, CA (Bernthal); and Department of Orthopedics, Leiden University Medical Center, Leiden, Netherlands (van de Sande).
Background: Patients with diffuse tenosynovial giant cell tumor (TGCT) face a high risk of recurrence, progression, and disability. This systematic review assesses the recent evidence of surgical, adjuvant, and systemic treatments for TGCT.
Methods: We searched PubMed and Ovid with the terms "Giant cell tumor of tendon sheath" OR "pigmented villonodular synovitis" OR "tenosynovial giant cell" AND "treatment" OR "surgery. Read More